Skip to content

ICR.med

Active
Private limited companyfounded 20251 yr activeLangekant 12, 3220 Holsbeek, BelgiumKBO/BCE: BE 1022.063.264
Summary

ICR.med has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €34k and a net result of €29k. Its solvency ranks better than 59% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
94 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency97
Growth-
Track record67
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3k at 30 days acceptable
Liquidity ample (current ratio 3.55; short-term debt: 28.2% and cash: 34.5% of total assets), and 28.2% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
71.8%
Return on assets
61.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
9 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€34k
Total assets
€47k
Net result
€29k
Working capital
€34k

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Equity and liabilities €47k
Equity €34k
Debt €13k
Debt finances 28.2% of the balance-sheet total.
Key figures and ratios
2025 value
Current ratio
3.55
Debt to equity
0.39
ROE
85.3%
ROA
61.3%
Debt ≤ 1 year
€13k
Income taxes
€8k
Filed annual accounts As filed with the NBB · 2025 · 28 lines
Balance sheet Code2025
Assets
Total assets20/58€47k
Current assets29/58€47k
Amounts receivable within one year40/41€26k
Trade receivables40€21k
Other amounts receivable41€5k
Cash at bank and in hand54/58€16k
Deferred charges and accrued income490/1€5k
Equity and liabilities
Total equity and liabilities10/49€47k
Equity10/15€34k
Contributions10/11€5k
Profit (loss) carried forward14€29k
Amounts payable17/49€13k
Amounts payable within one year42/48€13k
Trade debts44€5k
Suppliers440/4€5k
Taxes, remuneration and social security45€8k
Taxes450/3€8k
Income statement Code2025
Gross operating margin9900€37k
Operating profit (loss)9901€37k
Financial income75/76B€111
Recurring financial income75€111
Financial charges65/66B€66
Recurring financial charges65€66
Profit (loss) for the period before taxes9903€37k
Income taxes67/77€8k
Profit (loss) for the period9904€29k
Profit (loss) for the period to be appropriated9905€29k
Appropriation of the result
Profit (loss) to be appropriated9906€29k

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
22-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Holsbeek · 1 establishment unit since 2025
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Langekant 123220 Holsbeek
Ground area
627 m²
Building footprint
109 m²
Volume, LiDAR
698 m³
Parcel 24043A0044/00A007, Flanders · tallest building 9.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ICR.med
Langekant 12, 3220 HolsbeekSpecialist medical practice
since 20252.373.152.114
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24043A0044/00A007 Flanders 627 m² 1 · 109 m² 9.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 4,288 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded07-04-2025
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.